Write from this board Add posts Share
Loading the board
Loading the board
80 posts from @Incyte, Sep 2025 to Aug 2026: a typical post earns 2 likes. That is more than 19% of the 275 other S&P 500 companies we hold content for. About 1 in 6 of their posts opens with a number. Posts with an image or video earn a median of 2 likes (73 posts); text alone 4 likes (7).
| Post | Topic | Likes | Replies | Reposts | Score | Posted | Actions |
|---|---|---|---|---|---|---|---|
| @IncyteWe are excited to announce a strategic collaboration with @EdisonSci to employ the Kosmos … | AI | 20 | 2 | — | 12 | ||
| @IncyteWe’re proud to share that we have been named to LinkedIn’s inaugural Philadelphia Top Comp… | Hiring | 7 | 3 | — | 8 | ||
| @IncyteWe’ve announced positive topline results from the Phase 3 frontMIND trial in patients with… | Science | 7 | 0 | — | 1 | ||
| @IncyteIncyte announced an agreement to acquire Vega Therapeutics, a wholly owned subsidiary of @… | General | 6 | 0 | — | 0 | ||
| @IncyteIncyte is heading to the @hsforg Symposium on Hidradenitis Suppurativa Advances (SHSA), wh… | General | 5 | 2 | — | 5 | ||
| @IncyteWe’re focused on building a portfolio of scientifically differentiated compounds designed … | General | 4 | 0 | — | 0 | ||
| @IncyteFor the first time since acquiring VGA039 (latarcibart), we’re sharing data at the @isth C… | General | 4 | 0 | — | 0 | ||
| @IncyteToday at the American Society of Clinical Oncology® (@ASCO) Annual Meeting we shared new d… | Science | 4 | 0 | — | 0 | ||
| @IncyteIncyte and @genesismolai are expanding our collaboration designed to accelerate the discov… | General | 4 | 0 | — | 0 | ||
| @IncyteExcited for our partnership with Edison Scientific. Read more here: https://t.co/NF0LJbVeA… | General | 4 | 0 | — | 0 |